M. Artaç Et Al. , "The role of microsatellite instability to predict clinical benefit from irinotecan-based regimens in metastatic colorectal cancer," Turkish Journal of Cancer , vol.38, no.2, pp.49-56, 2008
Artaç, M. Et Al. 2008. The role of microsatellite instability to predict clinical benefit from irinotecan-based regimens in metastatic colorectal cancer. Turkish Journal of Cancer , vol.38, no.2 , 49-56.
Artaç, M., Pehlivan, S., Akcan, S., Pehlivan, M., Gelen, T., Itirli, G., ... Aksoy, N.(2008). The role of microsatellite instability to predict clinical benefit from irinotecan-based regimens in metastatic colorectal cancer. Turkish Journal of Cancer , vol.38, no.2, 49-56.
Artaç, Mehmet Et Al. "The role of microsatellite instability to predict clinical benefit from irinotecan-based regimens in metastatic colorectal cancer," Turkish Journal of Cancer , vol.38, no.2, 49-56, 2008
Artaç, Mehmet Et Al. "The role of microsatellite instability to predict clinical benefit from irinotecan-based regimens in metastatic colorectal cancer." Turkish Journal of Cancer , vol.38, no.2, pp.49-56, 2008
Artaç, M. Et Al. (2008) . "The role of microsatellite instability to predict clinical benefit from irinotecan-based regimens in metastatic colorectal cancer." Turkish Journal of Cancer , vol.38, no.2, pp.49-56.
@article{article, author={Mehmet Artaç Et Al. }, title={The role of microsatellite instability to predict clinical benefit from irinotecan-based regimens in metastatic colorectal cancer}, journal={Turkish Journal of Cancer}, year=2008, pages={49-56} }